Faropenem: Broad-spectrum antibiotic in the penem class . The drug is taken orally and may combat resistant strains of bacteria.
However, additional large scale animal testing is required to determine the cellular toxicity and stablity/half-life of dN4 and dC4 for pharmaceutical applications. Although intravenous administration of dN4 or dC4 enhanced survival, it should be noted that this required daily administration for three days to achieve significant results. Alternatively, the sample number was small as this…